Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Cancer Research
|
October 1, 1984
Expression of drug sensitivity and tumorigenicity in intraspecies hybrids between 9-hydroxyellipticine-sensitive and -resistant cells
J J Rémy, J Belehradek, A Jacquemin-Sablon
European Cytokine Network
|
November 5, 1997
Host's immune response in electrotherapy of murine tumors by direct current
D Miklavcic, D An, J Belehradek, et al.
Biochemical Pharmacology
|
December 21, 1991
Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture
B Poddevin, S Orlowski, J Belehradek, et al.
International Journal of Cancer
|
December 15, 1974
Actinomycin-D-resistant in vitro mouse cell line derived from a methylcholanthrene-induced sarcoma: decrease of malignancy and antigenic characteristics
J Belehradek, J L Biedler, M Thonier, et al.
Cancer Research
|
October 1, 1986
Uptake, cytofluorescence, and cytotoxicity of oxazolopyridocarbazoles (amino acid-ellipticine conjugates) in murine sarcoma cells
A K Larsen, J Paoletti, J Belehradek, et al.
Biochemical Pharmacology
|
December 15, 1988
Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs
S Orlowski, J Belehradek, C Paoletti, et al.
Cancer Research
|
November 15, 1993
Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized
O Tounekti, G Pron, J Belehradek, et al.
Biochemical Pharmacology
|
July 19, 1994
Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity
G Pron, J Belehradek, S Orlowski, et al.
The Biochemical Journal
|
July 15, 1996
Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators
S Orlowski, L M Mir, J Belehradek, et al.
European Cytokine Network
|
May 11, 1992
Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses
L M Mir, S Orlowski, B Poddevin, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Cancer Research
|
October 1, 1984
Expression of drug sensitivity and tumorigenicity in intraspecies hybrids between 9-hydroxyellipticine-sensitive and -resistant cells
J J Rémy, J Belehradek, A Jacquemin-Sablon
European Cytokine Network
|
November 5, 1997
Host's immune response in electrotherapy of murine tumors by direct current
D Miklavcic, D An, J Belehradek, et al.
Biochemical Pharmacology
|
December 21, 1991
Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture
B Poddevin, S Orlowski, J Belehradek, et al.
International Journal of Cancer
|
December 15, 1974
Actinomycin-D-resistant in vitro mouse cell line derived from a methylcholanthrene-induced sarcoma: decrease of malignancy and antigenic characteristics
J Belehradek, J L Biedler, M Thonier, et al.
Cancer Research
|
October 1, 1986
Uptake, cytofluorescence, and cytotoxicity of oxazolopyridocarbazoles (amino acid-ellipticine conjugates) in murine sarcoma cells
A K Larsen, J Paoletti, J Belehradek, et al.
Biochemical Pharmacology
|
December 15, 1988
Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs
S Orlowski, J Belehradek, C Paoletti, et al.
Cancer Research
|
November 15, 1993
Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized
O Tounekti, G Pron, J Belehradek, et al.
Biochemical Pharmacology
|
July 19, 1994
Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity
G Pron, J Belehradek, S Orlowski, et al.
The Biochemical Journal
|
July 15, 1996
Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators
S Orlowski, L M Mir, J Belehradek, et al.
European Cytokine Network
|
May 11, 1992
Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host's defenses
L M Mir, S Orlowski, B Poddevin, et al.
Page
of 5